ClinicalTrials.gov

History of Changes for Study: NCT04198337
Endoscopic Full Thickness Resection for Gastric GIST (EFTR)
Latest version (submitted November 4, 2023) on ClinicalTrials.gov
  • A study version is represented by a row in the table.
  • Select two study versions to compare. One each from columns A and B.
  • Choose either the "Merged" or "Side-by-Side" comparison format to specify how the two study versions are to be displayed. The Side-by-Side format only applies to the Protocol section of the study.
  • Click "Compare" to do the comparison and show the differences.
  • Select a version's Submitted Date link to see a rendering of the study for that version.
  • The yellow A/B choices in the table indicate the study versions currently compared below. A yellow table row indicates the study version currently being viewed.
  • Hover over the "Recruitment Status" to see how the study's recruitment status changed.
  • Study edits or deletions are displayed in red.
  • Study additions are displayed in green.
Study Record Versions
Version A B Submitted Date Changes
1 December 12, 2019 None (earliest Version on record)
2 February 1, 2021 Study Status and Sponsor/Collaborators
3 February 21, 2022 Study Status
4 November 4, 2023 Study Status
Comparison Format:

Scroll up to access the controls

Study NCT04198337
Submitted Date:  December 12, 2019 (v1)

Open or close this module Study Identification
Unique Protocol ID: CREC 2014.293-T
Brief Title: Endoscopic Full Thickness Resection for Gastric GIST (EFTR)
Official Title: Prospective Clinical Study on Safety and Effectiveness of Endoscopic Full Thickness Resection for Treatment of Patients With Gastric Gastrointestinal Stromal Tumors (GIST)
Secondary IDs:
Open or close this module Study Status
Record Verification: December 2019
Overall Status: Recruiting
Study Start: August 1, 2014
Primary Completion: December 31, 2020 [Anticipated]
Study Completion: December 31, 2021 [Anticipated]
First Submitted: December 12, 2019
First Submitted that
Met QC Criteria:
December 12, 2019
First Posted: December 13, 2019 [Actual]
Last Update Submitted that
Met QC Criteria:
December 12, 2019
Last Update Posted: December 13, 2019 [Actual]
Open or close this module Sponsor/Collaborators
Sponsor: Chinese University of Hong Kong
Responsible Party: Principal Investigator
Investigator: Philip Wai Yan Chiu
Official Title: Professor
Affiliation: Chinese University of Hong Kong
Collaborators:
Open or close this module Oversight
U.S. FDA-regulated Drug: No
U.S. FDA-regulated Device: No
Data Monitoring: No
Open or close this module Study Description
Brief Summary: This is a clinical trial to evaluate the efficacy and safety of endoscopic full thickness resection for treatment of gastric GIST
Detailed Description: To evaluate the clinical safety and efficacy of endoscopic full thickness resection (EFTR) for treatment of gastric GIST. A total of 30 patients will be recruited
Open or close this module Conditions
Conditions: Gastric GIST
Keywords:
Open or close this module Study Design
Study Type: Interventional
Primary Purpose: Treatment
Study Phase: Not Applicable
Interventional Study Model: Single Group Assignment
Number of Arms: 1
Masking: None (Open Label)
Allocation: N/A
Enrollment: 30 [Anticipated]
Open or close this module Arms and Interventions
Arms Assigned Interventions
Experimental: Endoscopic Full Thickness Resection
Resection of the gastric GIST by ESD techniques followed by endoscopic closure of defect with suturing or clips and loop
Procedure: Endoscopic Full Thickness Resection
Endoscopic full thickness resection achieved by resecting the submucosal tumor using retraction techniques and submucosal dissection, followed by closure
Open or close this module Outcome Measures
Primary Outcome Measures:
1. Complete resection of GIST
[ Time Frame: 30 days ]

Complete resection of the GIST defined by en-bloc resection in one piece by endoscopy with clear resection margins
Secondary Outcome Measures:
1. Adverse event rate
[ Time Frame: 30 days ]

Adverse event as defined by presence of either postoperative bleeding or leakage after closure
2. Perioperative mortality
[ Time Frame: 30 days ]

Death within 30 days after procedure
3. Histolology assessment
[ Time Frame: 30 days ]

Histology outcome as defined by any involvement of the tumor margins after resection
4. Hospital stay
[ Time Frame: 30 days ]

Length of stay in hospital
5. technical success in complete resection
[ Time Frame: 1 day ]

Technical success defined by complete endoscopic resection, closure of the defect and delivery of the specimen per orally without need of conversion to laparoscopic surgery
Open or close this module Eligibility
Minimum Age: 18 Years
Maximum Age: 80 Years
Sex: All
Gender Based:
Accepts Healthy Volunteers: No
Criteria:

Inclusion Criteria:

  1. Age > 18 and ≤ 80
  2. Gastric submucosal tumors located at cardia, lesser curvature and antrum
  3. Size of the submucosal tumor between 10mm to 30mm as assessed by endoscopic

Exclusion Criteria:

  1. Patients who are considered as unfit for general anesthesia
  2. ASA class ≥ IV or moribund patients
  3. Pregnancy
  4. Gastric submucosal tumors located at greater curvature and fundus
Open or close this module Contacts/Locations
Central Contact Person: Philip Wai Yan Y Chiu, MD, FRCSEd
Telephone: +85235053952
Email: philipchiu@surgery.cuhk.edu.hk
Central Contact Backup: Man Yee Yung
Telephone: +35052956
Email: myyung@surgery.cuhk.edu.hk
Study Officials: Philip Wai Yan Chiu, MD, FRCSEd
Principal Investigator
Chinese University of Hong Kong
Locations: China, Outside Of US & Canada
Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong
[Recruiting]
Hong Kong, Outside Of US & Canada, China, 00000
Contact:Contact: Philip WY Chiu, MD 85235053952 philipchiu@surgery.cuhk.edu.hk
Contact:Contact: Man Yee Yung 85235052956 myyung@surgery.cuhk.edu.hk
Open or close this module IPDSharing
Plan to Share IPD: Undecided
Open or close this module References
Citations:
Links:
Available IPD/Information:

Scroll up to access the controls Scroll to the Study top

U.S. National Library of Medicine | U.S. National Institutes of Health | U.S. Department of Health & Human Services